OTTAWA, CANADA — (Marketwired) — 03/15/16 — WiLAN (TSX: WIN)(NASDAQ: WILN) today announced the Company will present at IAM–s NPE 2016 Conference being held at Convene–s Financial District Event Center in New York. The presentation will take place on Tuesday, March 22, 2016 at 9:30am Eastern Time. Presenting from management will be Jim Skippen, President & Chief Executive Officer.About WiLANWiLAN is one of the most successful patent licensing companies in the world and helps companies
OTTAWA, CANADA — (Marketwired) — 02/10/16 — Wi-LAN Inc. ("WiLAN" or the "Company") (TSX: WIN)(NASDAQ: WILN) today announced that the Toronto Stock Exchange (the "TSX") had accepted its Notice of Intention to Make a Normal Course Issuer Bid (the "Notice"). Pursuant to the Notice, WiLAN may purchase for cancellation up to 11,762,446 issued and outstanding WiLAN common shares ("Common Shares") representing approximately 10% of the 117,624,467 C
OTTAWA, CANADA — (Marketwired) — 02/08/16 — WiLAN (TSX: WIN) (NASDAQ: WILN) today announced that it has filed its Form 40-F with the U.S. Securities and Exchange Commission. A copy of the Form 40-F is available on the WiLAN website at .WiLAN shareholders may request a printed copy of the complete audited financial statements, free of charge by emailing WiLAN investor relations at or by regular mail at Investor Relations, Wi-LAN Inc., 303 Terry Fox Drive, Suite 300, Ottawa, Ontario, K2K 3J1
OTTAWA, CANADA — (Marketwired) — 01/25/16 — WiLAN (TSX: WIN)(NASDAQ: WILN) will release its financial results for the fourth quarter and year ended December 31, 2015, on Thursday, February 4, 2016.Following the release of its fourth quarter and fiscal year 2015 financial results, WiLAN will host a conference call and audio webcast with Jim Skippen, CEO and Shaun McEwan, CFO at 10:00 AM Eastern Time the same day.Webcast InformationA live audio webcast will be available atDial-in InformationR
OTTAWA, ONTARIO — (Marketwired) — 01/25/16 — WiLAN (TSX: WIN)(NASDAQ: WILN) today announced that the Company–s subsidiary, Advanced Microscopy, Inc., has entered into a license agreement with Thermo Fisher Scientific Inc. The license relates to technology that provides enhanced image processing capabilities. Potential applications relate to the life sciences, material sciences, and semiconductor research.The license resolves litigation pending in the District of Delaware. The consideration
OTTAWA, CANADA — (Marketwired) — 01/19/16 — WiLAN (TSX: WIN)(NASDAQ: WILN) today announced that the Company–s subsidiary, North Star Innovations, Inc., has entered into a patent license agreement with GLOBALFOUNDRIES Inc., which provides foundry and application-specific integrated circuit (ASIC) products and services. The North Star Innovations portfolio was acquired by WiLAN in October 2015 from Freescale Semiconductor.The consideration paid to WiLAN and all other terms of the license agr
OTTAWA, CANADA — (Marketwired) — 01/13/16 — WiLAN (TSX: WIN)(NASDAQ: WILN) today announced that the Company–s subsidiary, Advanced Microscopy, Inc., has entered into a license agreement with FEI Company. The license relates to technology that provides enhanced image processing capabilities. Potential applications relate to the life sciences, material sciences, and semiconductor research.The license resolves litigation pending in the District of Delaware. The consideration to be paid to WiL
OTTAWA, CANADA — (Marketwired) — 01/11/16 — WiLAN (TSX: WIN)(NASDAQ: WILN) today announced that the Company–s subsidiary, Polaris Innovations Limited, has entered into a patent license agreement with GLOBALFOUNDRIES Inc., for patents related to processes used in its foundry services and patents related to application-specific integrated circuit (ASIC) products. The licensed patents are part of the Qimonda portfolio, which was acquired by WiLAN in June 2015 from Infineon Technologies AG.&qu
OTTAWA, CANADA — (Marketwired) — 01/06/16 — WiLAN (TSX: WIN)(NASDAQ: WILN) today announced that the Company–s subsidiary, Advanced Microscopy, Inc., has entered into a license agreement with BioTek Instruments, Inc. The license relates to technology that provides enhanced image processing capabilities. Potential applications relate to the life sciences, material sciences, and semiconductor research.The license resolves litigation pending in the District of Delaware. The consideration to be
